The way that we think about smoldering multiple myeloma (SMM) has continued to see evolution in the plasma cell dyscrasia space. If this diagnosis portends a higher risk of developing multiple myeloma, how should we manage patients to prevent possible end-organ damage? Is it a one-size-fits-all approach or are there some patients who are higher risk for progression than others? We cover this and so much more in this new episode!
This episode is brought to you by Primum
Content:
- What is smoldering multiple myeloma (SMM)?
- What are higher risk features of SMM?
- What are landmark studies in SMM?
- To treat or not to treat?
** This episode is brought to you by Primum: www.primum.co
** Want to review the show notes for this episode and others? Check out our website.
Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!
Twitter: @TheFellowOnCall
Instagram: @TheFellowOnCall
Listen in on: Apple Podcast, Spotify, and Youtube
The Fellow on Call: The Heme/Onc Podcast